Purchase Order 80NSSC20P2167
Award Date
10/21/20
Potential Completion Date
10/20/21
Potential Value
$114K
Federal Agency
Shared Services Center
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $233,302.47 award is for reagents to support the NASA GeneLab project, which requires various reagents compatible with Illumina sequencing platforms like the NovaSeq 6000 and iSeq 100 for generating sequencing libraries, clusters, and data from biological samples...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic sequencing solutions. The order is for an Illumina NovaSeq 6000 sequencing system with a C-Bot instrument, with a potential value of $1,122,109.40. The award has no set-aside designation. Illumina has previously received prime federal contracts from agencies...
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomics analysis instruments and reagents. The $156,933.75 contract provides Illumina sequencing systems, reagents, and support services to the GeneLab, which requires the Illumina sequencers for its daily work. This award is not associated with any set-aside program. Illumina has a history of providing sequencing equipment...
This is a $86,760.00 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract provides a NovaSeq 6000 sequencing service agreement with an estimated completion date of June 28, 2025. There is no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA...
This is a firm fixed price purchase order awarded by the Department of the Navy's Naval Supply Systems Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract, valued at $135,878.00, is for the provision of a NovaSeq sequencing system, related consumables, and a 0.25 maintenance plan. The contract has a completion date of January 12, 2025 and was awarded on December 28, 2023. This award does not appear to be associated with a larger...
This is a firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a Defense agency, to Illumina, Inc. for the provision of a NovaSeq X Plus Sequencing System. The $1,083,750.00 contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems, reagents, and related services to support research and...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Illumina, Inc. for $19,824.00 to provide annual preventative maintenance services for a NovaSeq 6000 sequencing system. The contract has no set-aside designation. Based on Illumina's past federal contract work, the company has a history of providing a range of genomic sequencing systems, reagents, and related services to support research and diagnostics...
This is a $125,814.00 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc. The contract is for NovaSeq Silver Support services, which includes the provision of sequencing systems, reagents, and maintenance services to support genomic sequencing and analysis. Illumina is the sole manufacturer of the NovaSeq and related instruments used under this order. The contract has no set-aside designation and is not associated with a larger...
This firm fixed-price delivery order was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. for the purchase of various NovaSeq 6000 sequencing system reagent kits and accessories. The total ceiling value of the contract is $90,412.75 and it has an ultimate completion date of September 2, 2025. This award is not associated with a set-aside program. Illumina has previously held prime federal contracts and subcontracts...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency of the U.S. government, to Illumina, Inc. for $98,250.35. The award is not associated with a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, will provide a range of goods and services to support genomic sequencing and analysis, including various NextSeq, NovaSeq, MiSeq, and...